Original Source(s)
Related Content
AACE 2026: Will AI replace endocrinologists?
The same technology drawing patients away from clinic may also improve the patient-physician relationship.
by Jared Bilski
April 22, 2026
-
3 min
Anti-Diabetic Retinopathy Molecular Mechanism of Dihuang Yinzi: Insights from Network Pharmacology, Metabolomics, and Microbiome Analysis
by Chai, Jinmiao , Gui, Wanwei , Zhang, Junlong , He, Wenbin , Li, Qinqing
April 28, 2026
Investigational OCTA Devices Show Promise in Diabetic Disease Assessment
At Retina World Congress, Patricio G. Schlottmann, MD, discussed investigational widefield OCTA platforms made by Chinese company TowardPi Medical.
May 14, 2026
-
2 min